NCT05078840View on ClinicalTrials.gov

PET Adapted Treatment of Patients With Limited Stage DLBCL and no Risk Factors

RecruitingOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

June 1, 2024

Study Completion Date

June 1, 2025

Conditions
Lymphoma, Non-Hodgkin's, Adult
Interventions
OTHER

Evaluation of first line treatment in patients with stage I and II LBCL

Evaluation of first line treatment in patients with stage I and II LBCL, without poor prognostic factors with treatment adapted to PET-CT after 3 R-CHOP

Trial Locations (7)

Unknown

RECRUITING

Hospital Italiano de La Plata, La Plata

RECRUITING

Instituto Privado de Hematologia y Hemoterapia, Paraná

RECRUITING

IDHEA Clínica Hematológica, Rosario

RECRUITING

FUNDALEU, CABA

RECRUITING

Hospital Italiano de Buenos Aires, CABA

RECRUITING

Clínica Universitaria Reina Fabiola, Córdoba

RECRUITING

Hospital Privado de Córdoba, Córdoba

All Listed Sponsors
lead

Grupo Argentino de Tratamiento de la Leucemia Aguda

OTHER